Non-esterified fatty acid metabolism and postprandial lipaemia

Atherosclerosis

Volumn 141, Issue SUPPL. 1, 1998, Pages

  Frayn, Keith N ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Acylation stimulating protein; Adipose tissue; Hormone sensitive lipase; Lipoprotein lipase; Non esterified fatty acids; Postprandial lipaemia

Indexed keywords

APOLIPOPROTEIN B; CHYLOMICRON; FATTY ACID; INSULIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ACYLATION; ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; ESTERIFICATION; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; GLUCOSE METABOLISM; HYPERLIPIDEMIA; LIPID METABOLISM; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; PRIORITY JOURNAL;

EID: 0031743113     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00216-0     Document Type: Article

References (52)

1. Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci 1996;90:243-53.
2. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 1995;38:1213-7.
3. Yeaman SJ, Smith GM, Jepson CA, Wood SL, Emmison N. The multifunctional role of hormone-sensitive lipase in lipid metabolism. Adv Enz Reg 1994;34:355-70.
4. Langin D, Holm C, Lafontan M. Adipocyte hormone-sensitive lipase: a major regulator of lipid metabolism. Proc Nutr Soc 1996;55:93-109.
5. Strong P, Anderson R, Coates J, Ellis F, Evans B, Gurden MF, Johnstone J, Kennedy, I, Martin DP. Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236. Clin Sci 1993;84:663-9.
6. Carlson LA, Oro L. Effect of treatment with nicotinic acid for one month on serum lipids in patients with different types of hyperlipidemia. Atherosclerosis 1973;18:1-9.
7. Farmer JA, Gotto AM Jr. Currently available hypolipidaemic drugs and future therapeutic developments. Baillières Clin Endocrinol Metab 1995;9:825-47.
8. Worm D, Henriksen JE, Vaag A, Thye-Rønn P, Melander A, Beck-Nielsen H. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab 1994;78:717-21.
9. Potts JL, Fisher RM, Humphreys SM, Coppack SW, Gibbons GF, Frayn KN. Peripheral triacylglycerol extraction in the fasting and post-prandial states. Clin Sci 1991;81:621-6.
10. Karpe F, Hultin M. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. J Lipid Res 1995;36:1557-66.
11. Potts JL, Coppack SW, Fisher RM, Humphreys SM, Gibbons GF, Frayn KN. Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol 1995;268:E588-94.
12. van der Vusse GJ, Reneman RS. Lipid metabolism in muscle. In: Rowell LB, Shepherd JT, editors. Handbook of physiology, section 12. New York: American Physiological Society, 1996:952-94.
13. Samra JS, Simpson EJ, Clark ML, Forster CD, Humphreys SM, Macdonald IA, Frayn KN. Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism. Am J Physiol 1996;271:E834-9.
14. Heimberg M, Dunn GD, Wilcox HG. The derivation of plasma-free fatty acids from dietary neutral fat in man. J Lab Clin Med 1974;83:393-402.
15. Binnert C, Laville M, Pachiaudi C, Rigalleau V, Beylot M. Use of gas chromatography/isotope ratio-mass spectrometry to study triglyceride metabolism in humans. Lipids 1995;30:869-73.
16. Fielding BA, Frayn KN, Halliday D, Bannister PA, Callow J, Venkatesan S. Rapid entry of dietary fatty acids into the plasma non-esterified fatty acid pool. Proc Nutr Soc 1996;55:162A.
17. Frayn KN, Fielding BA, Humphreys SM, Coppack SW. Nutritional influences on human adipose tissue metabolism. Biochem Soc Trans 1996;24:422-6.
18. Sniderman AD, Cianflone K, Summers LKM, Fielding BA, Frayn KN. The acylation-stimulating protein pathway and regulation of postprandial metabolism. Proc Nutr Soc 1997;56:703-12.
19. Sniderman AD, Cianflone K, Frayn K. The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyper-apo B. Diabetologia 1997;40:S152-4.
20. Sniderman A, Cianflone K, Arner P, Summers L, Frayn K. The adipocyte, fatty acid trapping and atherogenesis. Arterioscler Thromb Vasc Biol 1998;18:147-51.
21. Frayn KN, Summers LKM, Fielding BA. Regulation of the plasma non-esterified fatty acid concentration in the postprandial state. Proc Nutr Soc 1997;56:713-21.
22. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich POJ. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci USA 1980;77:604-8.
23. Chen Y-DI, Golay A, Swislocki ALM, Reaven GM. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocr Metab 1987;64:17-21.
24. Del Prato S, Enzi G, Vigili de Kreutzenberg S, Lisato G, Riccio A, Maifreni L, Iori E, Zurlo F, Sergi G, Tiengo A. Insulin regulation of glucose and lipid metabolism in massive obesity. Diabetologia 1990;33:228-36.
25. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocr Metab 1991;72:96-107.
26. McKeigue PM, Laws A, Chen YD, Marmot MG, Reaven GM. Relation of plasma triglyceride and apo B levels to insulin-mediated suppression of nonesterified fatty acids. Possible explanation for sex differences in lipoprotein pattern. Arterioscler Thromb 1993;13:1187-92.
27. Roust LR, Jensen MD. Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 1993;42:1567-73.
28. Aitman TJ, Godsland IF, Farren B, Crook D, Wong HJ, Scott J. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1997;17:748-54.
29. Byrne CD, Wareham NJ, Day NE, McLeish R, Williams DRR, Hales CN. Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance. Diabetologia 1995;38:1358-66.
30. Fielding BA, Callow J, Owen RM, Samra JS, Matthews DR, Frayn KN. Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr 1996;63:36-41.
31. Frayn KN, Coppack SW, Fielding BA, Humphreys SM. Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enz Reg 1995;35:163-78.
32. Abumrad NA, el Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993;268:17665-8.
33. Harmon CM, Abumrad NA. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 1993;133:43-49, issn: 0022-2631.
34. Leboeuf B. Regulation of fatty acid esterification in adipose tissue incubated in vitro. In: Renold AE, Cahill GF, editors. Handbook of physiology, section 5: adipose tissue. Washington DC: American Physiological Society, 1965:385-91.
35. Campbell PJ, Carlson MG, Hill JO, Nurjhan N. Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification. Am J Physiol 1992;263:E1063-9.
36. Frayn KN, Shadid S, Hamlani R, Humphreys SM, Clark ML, Fielding BA, Boland O, Coppack SW. Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am J Physiol 1994;266:E308-17.
37. Sniderman A, Baldo A, Cainflone K. The potential role of acylation stimulating protein as a determinant of plasma triglyceride clearance and intracellular triglyceride synthesis. Curr Opin Lipidol 1992;3:202-7.
38. Baldo A, Sniderman AD, St-Luce S, Avramoglu RK, Maslowska M, Hoang B, Monge JC, Bell A, Mulay S, Cianflone K. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993;92:1543-7.
39. Maslowska M, Scantlebury T, Germinario R, Cianflone K. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. J Lipid Res 1997;38:1-11.
40. Sniderman AD, Cianflone K. The adipsin-acylation-stimulating protein pathway and microenvironmental metabolic regulation. World Rev Nutr Diet 1997;80:44-81.
41. Cianflone K, Sniderman AD, Summers LKM, Fielding BA, Frayn KN. Postprandial generation of acylation stimulating protein by human adipose tissue in vivo. Proc Nutr Soc 1997;56:190A.
42. Saleh J, Summers L, Cianflone K, Fielding B, Sniderman A, Frayn KN. Coordinated release of acylation stimulating protein and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 1998;39:884-91.
43. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-9.
44. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-46.
45. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983;72:1737-47.
46. Svedberg J, Björntorp P, Smith U, Lönnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 1990;39:570-4.
47. Peterson J, Bihain BE, Bengtsson-Olivecrona G, Deckelbaum RJ, Carpentier Y, Olivecrona T. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc Natl Acad Sci USA 1990;87:909-13.
48. Saxena U, Witte LD, Goldberg IJ. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem 1989;264:4349-55.
49. Arii K, Suehiro T, Yamamoto M, Ito H, Hashimoto K. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism 1997;46:1166-70.
50. Lagrost L, Florentin E, Guyard Dangremont V, Athias A, Gandjini H, Lallemant C, Gambert P. Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. Arterioscler Thromb Vasc Biol 1995;15:1388-96.
51. Steinberg HO, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997;100:1230-9.
52. Singer P, Gödicke W, Voigt S, Hajdu I, Weiss M. Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension 1985;7:182-6.